Literature DB >> 3511864

The prognostic value of the modifications of the Dukes' C class of colorectal cancer. An analysis of the NSABP clinical trials.

N Wolmark, B Fisher, H S Wieand.   

Abstract

This study was carried out in an effort to resolve the dilemma created by three proposed modifications of the Dukes' C class of colorectal cancer. Each modification is based on a separate prognostic discriminant characterized by: the level of histologically positive nodes, the depth of tumor penetration, and the number of histologically positive nodes. Data were derived from 844 patients with Dukes' C lesions randomized into two prospective clinical trials of the NSABP; the mean time on study was 41 months. Analysis of the three modifications as independent variables without regard for possible confounding effects disclosed that each had a highly significant predictive capacity. When each discriminant was examined, this time adjusting for the contribution of the other two discriminants, the effect attributable to the level of positive nodes was markedly attenuated. Thus, the level of positive nodes provided little information over and above that of depth of tumor penetration and the number of positive nodes. Of the two latter discriminants, although both were significant predictors of survival, the number of positive nodes appeared to be the strongest factor. Using both depth of penetration and the number of positive nodes, a unique Dukes' C subset of patients could be identified with a prognosis at least as good as Dukes' B lesions; this group was characterized by partial tumor penetration and the presence of 1-4 positive nodes. It is concluded that both depth of penetration and the number of positive nodes represent appropriate modifications of the initial Dukes scheme, and one discriminant should not be used to the exclusion of the other. The data raise serious doubts relative to the propriety of newly proposed TNM classification schemes that fail to utilize the number of positive nodes as a predictive discriminant.

Entities:  

Mesh:

Year:  1986        PMID: 3511864      PMCID: PMC1251056          DOI: 10.1097/00000658-198602000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Carcinoma of the rectum; a study of factors influencing survival following combined abdominoperineal resection of the rectum.

Authors:  E J DUNNING; T E JONES; J B HAZARD
Journal:  Ann Surg       Date:  1951-02       Impact factor: 12.969

2.  The spread of carcinoma of the colon and rectum.

Authors:  R S GRINNELL
Journal:  Cancer       Date:  1950-07       Impact factor: 6.860

3.  Prognostic factors in carcinoma of the colon and rectum.

Authors:  E M Copeland; L D Miller; R S Jones
Journal:  Am J Surg       Date:  1968-12       Impact factor: 2.565

4.  Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma.

Authors:  J S Spratt; H J Spjut
Journal:  Cancer       Date:  1967-11       Impact factor: 6.860

5.  CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols.

Authors:  G Steele; S Ellenberg; K Ramming; M O'Connell; C Moertel; H Lessner; H Bruckner; J Horton; P Schein; N Zamcheck; J Novak; E D Holyoke
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

6.  Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report.

Authors:  G A Higgins; J H Amadeo; J McElhinney; J J McCaughan; R J Keehn
Journal:  Cancer       Date:  1984-01-01       Impact factor: 6.860

7.  Survival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancer.

Authors:  M E Pezim; R J Nicholls
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

8.  Tumor size and regional lymph node metastasis in colorectal cancer. A preliminary analysis from the NSABP clinical trials.

Authors:  N Wolmark; I Cruz; C K Redmond; B Fisher; E R Fisher
Journal:  Cancer       Date:  1983-04-01       Impact factor: 6.860

9.  Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum.

Authors:  A W Malcolm; N P Perencevich; R M Olson; J A Hanley; J T Chaffey; R E Wilson
Journal:  Surg Gynecol Obstet       Date:  1981-02

10.  Staging of colorectal cancer. The Australian clinico-pathological staging (ACPS) system compared with Dukes' system.

Authors:  N C Davis; E B Evans; J R Cohen; D E Theile
Journal:  Dis Colon Rectum       Date:  1984-11       Impact factor: 4.585

View more
  29 in total

1.  The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma.

Authors:  N Y Haboubi; P Clark; S M Kaftan; P F Schofield
Journal:  J R Soc Med       Date:  1992-07       Impact factor: 5.344

2.  Distal adenomatous polyps are rare in patients with inflammatory bowel disease.

Authors:  A Dixon; P Wurm; A Hart; R Robinson
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

3.  Prognostic value of additional pathological variables for long-term survival after curative resection of rectal cancer.

Authors:  Bojan Krebs; Miran Kozelj; Rajko Kavalar; Borut Gajzer; Eldar M Gadzijev
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

4.  Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes.

Authors:  Haruhisa Matsuguma; Izumi Oki; Rie Nakahara; Norihisa Ohata; Seiji Igarashi; Kiyoshi Mori; Shunsuke Endo; Kohei Yokoi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

5.  Apical-node metastasis in sigmoid colon or rectal cancer: is it a factor that indicates a poor prognosis after high ligation?

Authors:  Jin-Wook Yi; Taek-Gu Lee; Hye-Seung Lee; Seung Chul Heo; Seung-Yong Jeong; Kyu Joo Park; Sung-Bum Kang
Journal:  Int J Colorectal Dis       Date:  2011-07-08       Impact factor: 2.571

Review 6.  Is total pelvic exenteration reasonable primary treatment for rectal carcinoma?

Authors:  L F Williams; C B Huddleston; J L Sawyers; J R Potts; K W Sharp; S W McDougal
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

Review 7.  Reporting colorectal cancer.

Authors:  J R Jass; B C Morson
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

Review 8.  Staging of colorectal cancer.

Authors:  P H Chapuis; M F Dixon; L P Fielding; P H Gordon; P Hermanek; M Kyriakos; S D Nathanson; R C Newland; G D Oates; P Quirke
Journal:  Int J Colorectal Dis       Date:  1987-08       Impact factor: 2.571

9.  An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes' B and C rectal carcinoma. A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project.

Authors:  N Wolmark; B Fisher
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

10.  The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes.

Authors:  Hok Kwok Choi; Wai Lun Law; Jensen T C Poon
Journal:  BMC Cancer       Date:  2010-06-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.